Sequoia China-backed health tech unicorn Medlinker has set up a 500-million-yuan ($75.9 million) industry investment fund, while Gene+ Technology has closed over 250 million yuan ($38 million) in a Series B+ round of financing led by Huagai Capital.
Sequoia-backed health tech unicorn Medlinker debuts $76m fund
Chinese health tech unicorn Medlinker has partnered with state-owned investment firm Wuhan S&T Investment Company and an affiliate of China Merchants Bank to set up a 500-million-yuan ($75.9 million) fund to invest in startups working in the chronic disease management field, it announced on Tuesday.
